Corticosteroid Treatment in Septic Shock
Seminars in Respiratory and Critical Care Medicine · 01.02.2026 · 47 (01) · 086-097
DOI: 10.1055/a-2694-4823 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Respiratory and Critical Care Medicine, erschienen am 01.02.2026. Verfasst von Jiao Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Critical Care Medicine, Shanghai Jiao Tong University School of Medicine, Ruijin Hospital, Shanghai, China. Hauptthemen laut MEDLINE: Shock, Septic, Adrenal Cortex Hormones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 115 Literaturangaben. Gefördert von: French Ministry of Social Affairs and Health, Program d'Investissements d'Avenir, France 2030.
Themen: Sepsis
Abstract (Originalsprache)
Septic shock, the most severe manifestation of sepsis, is characterized by profound circulatory failure and carries the highest mortality risk among sepsis-related conditions. Current therapeutic strategies remain primarily supportive, emphasizing empirical antimicrobial therapy and advanced organ system support. The immunomodulatory properties of corticosteroids in sepsis pathophysiology have been extensively investigated since the 1970s, though current guidelines recommend corticosteroid therapy for sepsis patients, albeit with a weak evidence base. In this review, we explore the molecular underpinnings of corticosteroid activity in septic shock and clinical evidence from randomized controlled trials, with a special emphasis on the stabilization of hemodynamics and the impact on mortality outcomes. Furthermore, we analyze recent advances in pharmacodynamic understanding that may inform more targeted corticosteroid administration in septic shock.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Critical Care Medicine, Shanghai Jiao Tong University School of Medicine, Ruijin Hospital, Shanghai, China.
- Department of Critical Care, Fudan University Shanghai Cancer Center, Shanghai, China.
- Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
- Department of Intensive Care, APHP University Versailles Saint Quentin, University Paris Saclay, Raymond Poincaré Hospital, Garches, France.
- SEPSIS Institute, Institut Hospitalo Universitaire IHU-3, Garches, France.
- Laboratory of Infection and Inflammation, U1173, School of Medicine, INSERM, University Versailles Saint Quentin, University Paris Saclay, Garches, France.
Förderung
- French Ministry of Social Affairs and Health
- Program d'Investissements d'Avenir
- France 2030
- ERA PerMed
- Chinese National Scientific Foundation Committee
- Shanghai "Rising Stars of Medical Talents" Youth Development Program
- Shanghai “Rising Stars of Medical Talents” Youth Development Program
Zitieren
APA
Liu, J., Xing, Q., Pan, X., Zhang, S., Chen, D., & Annane, D. (2026). Corticosteroid Treatment in Septic Shock. Seminars in Respiratory and Critical Care Medicine, 47(01), 086-097. https://doi.org/10.1055/a-2694-4823
Vancouver
Liu J, Xing Q, Pan X, Zhang S, Chen D, Annane D. Corticosteroid Treatment in Septic Shock. Seminars in Respiratory and Critical Care Medicine. 2026;47(01):086-097. doi:10.1055/a-2694-4823
BibTeX
@article{Liu2026,
author = {Liu, Jiao and Xing, Qian and Pan, Xiaojun and Zhang, Sheng and Chen, Dechang and Annane, Djillali},
title = {Corticosteroid Treatment in Septic Shock},
journal = {Seminars in Respiratory and Critical Care Medicine},
year = {2026},
volume = {47},
number = {01},
pages = {086--097},
doi = {10.1055/a-2694-4823}
}
EUVIMED